GE HealthCare, a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, and MediView XR Inc., a leading clinical augmented reality med-tech company, announced the successful first installation and clinical cases using the OmnifyXR Interventional Suite[1] at North Star Vascular and Interventional in Minneapolis, Minnesota. 

MediView XR, Inc. is excited to announce the first inpatient utilization of its XR90 augmented reality-based surgical visualization and navigation system since its 510(k) clearance.
The first worldwide clinical case, a mediastinal lymph node biopsy, was performed by Dr. Bradley Pua, Chief of the Division of Interventional Radiology at NewYork-Presbyterian Hospital / Weill Cornell Medicine. Photo courtesy of NewYork-Presbyterian.

The article discusses how the XR90 system works, areas of application, clinical experiences, its potential impact on minimally invasive procedures, thoughts on the future direction of where the technology is headed and clinical insights from vascular and interventional radiologists and augmented reality luminaries Charles Martin, MD of Cleveland Clinic, Bradley Pua, MD, of Weill Cornell Medicine, Robert Short, MD, PhD, of Dayton VA Medical Center and Gaurav Gadodia, M.D. of VIR Chicago.

MediView has received 510(k) clearance from the U.S. Food and Drug Administration for its XR90 augmented reality-based surgical visualization and navigation platform. XR90 is intended to be used adjunctively for minimally invasive ultrasound and CT guided needle-based procedures for soft tissue and bone. This is the first 510(k) clearance for an AR device with live imaging combined with 3D XR visualization with pre- and intra-operative indications, which sets the stage for further advancements in augmented reality in the healthcare space.